Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model
eLife · 2025
DOI: 10.7554/elife.96925 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Han V Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, T-Lymphocytes, Cytotoxic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Veterans Affairs Scholarship Program, NIH HHS.
Abstract (Originalsprache)
Most human pancreatic ductal adenocarcinoma (PDAC) are not infiltrated with cytotoxic T cells and are highly resistant to immunotherapy. Over 90% of PDAC have oncogenic KRAS mutations, and phosphoinositide 3-kinases (PI3Ks) are direct effectors of KRAS. Our previous study demonstrated that ablation of Pik3ca in KPC ( Kras G12D ; Trp53 R172H ; Pdx1-Cre ) pancreatic cancer cells induced host T cells to infiltrate and completely eliminate the tumors in a syngeneic orthotopic implantation mouse model. Now, we show that implantation of Pik3ca −/− KPC (named αKO) cancer cells induces clonal enrichment of cytotoxic T cells infiltrating the pancreatic tumors. To identify potential molecules that can regulate the activity of these anti-tumor T cells, we conducted an in vivo genome-wide gene-deletion screen using αKO cells implanted in the mouse pancreas. The result shows that deletion of propionyl-CoA carboxylase subunit B gene ( Pccb ) in αKO cells (named p-αKO) leads to immune evasion, tumor progression, and death of host mice. Surprisingly, p-αKO tumors are still infiltrated with clonally enriched CD8 + T cells but they are inactive against tumor cells. However, blockade of PD-L1/PD1 interaction reactivated these clonally enriched T cells infiltrating p-αKO tumors, leading to slower tumor progression and improve survival of host mice. These results indicate that Pccb can modulate the activity of cytotoxic T cells infiltrating some pancreatic cancers and this understanding may lead to improvement in immunotherapy for this difficult-to-treat cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, United States.
- Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, United States.
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, United States.
- Department of Microbiology and Immunology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States.
- Center for Infectious Diseases, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States.
- Northport Veteran Affair Medical Center, Northport, New York, United States.
ORCID-Profile: Han V Han, Richard Z Lin
Förderung
- NCI NIH HHS
- Veterans Affairs Scholarship Program
- NIH HHS
- BLRD VA
- National Institutes of Health
Zitieren
APA
Han, H. V., Efem, R., Rosati, B., Lu, K., Maimouni, S., Jiang, Y. P., Montoya, V., Van Der Velden, A., Zong, W. X., & Lin, R. Z. (2025). Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model. eLife. https://doi.org/10.7554/elife.96925
Vancouver
Han HV, Efem R, Rosati B, Lu K, Maimouni S, Jiang YP, et al. Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model. eLife. 2025. doi:10.7554/elife.96925
BibTeX
@article{Han2025,
author = {Han, Han V and Efem, Richard and Rosati, Barbara and Lu, Kevin and Maimouni, Sara and Jiang, Ya-Ping and Montoya, Valeria and Van Der Velden, Ando and Zong, Wei-Xing and Lin, Richard Z},
title = {Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.96925}
}
EUVIMED